株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

コンシューマーヘルスケアの新パラダイム (2019年):今後の展望

Nicholas Hall's New Paradigms for CHC 2019: Over the Horizon

発行 Nicholas Hall & Company 商品コード 735793
出版日 ページ情報 英文 418 Pages
即納可能
価格
本日の銀行送金レート: 1USD=110.43円で換算しております。
Back to Top
コンシューマーヘルスケアの新パラダイム (2019年):今後の展望 Nicholas Hall's New Paradigms for CHC 2019: Over the Horizon
出版日: 2019年08月07日 ページ情報: 英文 418 Pages
概要

当レポートでは、世界のコンシューマーヘルスケア市場について調査し、ヘルスケアの動向、革新の領域、規制環境、主要セグメント、競合情勢、および長期的な収益成長のための実行可能な戦略などについて分析しています。

第1章 展望

第2章 コンシューマーヘルスケア (CHC) 市場:状況レポート

第3章 新興市場

第4章 ヘルスケアの動向

第5章 消費者との関わり

第6章 革新する方法 (遂に!)

第7章 規制

第8章 処方薬 (Rx) から市販薬 (OTC) への切り替え

第9章 大麻

第10章 性の健康

第11章 肥満

第12章 消化による健康

第13章 グリーンへと向かう

第14章 睡眠・気分・ストレス

第15章 薬用化粧品

第16章 流通

第17章 デジタル革命

第18章 競合 - 勝者・生存者・敗者

第19章 M&A

第20章 長期的な収益成長に向けたブランドの管理

目次

Why buy this report?

"In my usual forthright manner I explain the plain truth, what I think will work, what won't work and (sometimes) what I don't know. The emphasis is on actionable strategies. And to make that realistic, every global licence has a dedicated 2 hour Webinar to explain key learnings and how it will affect the subscriber's business prospects, with an option for a full one-day Forensics to go into more depth. I will conduct these Webinars and Forensics in person, just as have written every word that appears in the report, supported by a talented team of internal and external researchers."

Table of Contents

1. Looking over the Horizon

  • 15 Infinity Zones
  • Forecasts for the mainstream retail sector
  • Best Case
  • Worst Case
  • Model 1 (DtC) vs 2 (OTx)

2. CHC Market - Situation Report

  • 2014-18 (and a little further back)
  • What happened in 2018
  • North America
  • Europe
  • Japan
  • Australasia

3. Emerging Markets

  • Overview
  • BRICITS
  • 2nd tier
  • The new 3rd tier

4. Healthcare Trends

  • Upturn in some illnesses and conditions
  • Allergy (and allergy-associated asthma)
  • Obesity and diabetes
  • Autism Spectrum Disorders
  • Attention Deficit / Hyperactivity Disorder
  • Medical provision
  • How governments aim to reduce the healthcare "burden"
  • Big Pharma: Does it have a future in Consumer Healthcare
  • Why are pharma players exiting consumer healthcare?

5. Engaging with the Consumer

  • Demographics
  • Strepsils / Strefen - carving a niche as severe sore throat specialist
  • With less time, convenience is key for consumers
  • A rapidly growing middle class
  • The Ageing Consumer
  • Women vs Men
  • Is there a gender gap?
  • Defining the women's CHC market
  • Unmet needs: opportunities for successful switch
  • Building female franchises
  • Eve - dynamic ibuprofen brand with simple selling point
  • What about women's heart health?
  • "Femtech" potential
  • What about Men?
  • Defining the men's CHC market
  • Unmet needs: opportunities for successful switch and geographic expansion
  • Neutrogena - intelligent expansion via light masks and devices
  • Prevention & Lifestyle

6. How to Innovate (at last!)

  • Why CHC isn't innovating
  • Which new entries are the game-changers?
  • Innovation zones: delivery, devices, diagnostics
  • Innovation zones: new delivery systems
  • Innovation zones: medical devices for treatment, relief or prevention
  • What about smaller segments?
  • Innovation zones: diagnostics & monitoring
  • Thorne Research - premium VMS line moving into personalised nutrition

7. Regulation

  • The overall trend to deregulation and reregulation
  • Tighter regulation: aiming for improved safety
  • Addictive, dangerous and potentially fatal misuse
  • Children's medicines - going, going, gone, honey?
  • Supplements - regulated or not?
  • Medical devices - EU shows way to better regulation

8. Rx-to-OTC Switch

  • Why switch?
  • Switch models
  • US vs ROW: Can switch be profitable only in USA?
  • EU's Centralised Procedure
  • Recent switches: what went right / what went wrong?
  • Voltaren - leading topical analgesic thanks to strong identity and NPD
  • What's coming down the pipeline?

9. Cannabis

  • Regulatory
  • Other notable markets
  • Who are the cannabis industry leaders?

10. Sexual Health

  • Contraception
  • Oral contraceptives
  • Emergency contraception
  • Condoms
  • Vaginal rings
  • Spermicides
  • Diaphragms
  • Male contraceptive pills and gels
  • Prenatal VMS
  • Pregnancy tests
  • Fertility lubricants
  • FemTech
  • Fertility and birth control apps
  • Ovulation and fertility kits & monitors
  • Leading and latest devices
  • Erectile dysfunction
  • Generic competition increasing

11. Diabesity

  • Obesity
  • The market for weight loss drugs continues to be flat
  • OTC weight loss launches 2017-19
  • Fat binders, carb blockers & appetite suppressants
  • Meal replacements regaining prominence
  • Probiotics for weight loss
  • Limited evidence for many weight loss supplements
  • Weight loss apps, trackers & wearables
  • Diabetes
  • OTC market for diabetes care
  • Diabetes innovation
  • VMS options for diabetes have potential
  • Meal replacements and emerging ingredients
  • Eye care for diabetics

12. Health through Digestion

  • Probiotics
  • Probiotics market today (1): The markets, players and brands
  • Probiotics market today (2): The focus is on gut health
  • OMNi-BiOTiC - diverse European probiotics range
  • Food intolerance
  • Lactose intolerance
  • Other intolerances
  • Nutraceuticals
  • 12. Health through Digestion (cont.)
  • Rising investment in nutraceuticals & nutritionals
  • Foods making health claims in Japan
  • Nutraceuticals & nutritionals expanding fast in Asia
  • CH marketers must contend with food players in this sphere

13. Go Green

  • Herbal & natural products
  • "Pure" single-ingredient H&N supplements
  • Natural supplements for lifestyle
  • Burt's Bees - beeswax beauty brand boosted by natural heritage
  • Natural topical analgesics
  • Natural cough remedies
  • Zarbee's - honey-based cough remedy successfully diversified
  • Innovation
  • Immunity & detox
  • Immunity
  • Myriad other supplements for immunity
  • Detox
  • Hangover remedies

14. Sleep, Mood & Stress

  • Sleep disorders
  • Overview
  • OTCs & supplements
  • Recent developments
  • ZzzQuil - US diphenhydramine leader expands into herbal & naturals
  • Switch
  • Mental health, mood & stress
  • The next global epidemic
  • Products for mental health, mood & stress
  • Innovations
  • CBD - the hottest new medicine in mental health
  • Probiotics: the gastrointestinal tract is the "second brain"

15. Cosmeceuticals

  • Fortified cosmetics
  • Aesthetic treatments
  • Retinoids
  • Cannabis-infused skincare
  • Cosmeceutical supplements / beauty nutraceuticals

16. Distribution

  • Why Pharmacy Point-of-Care?
  • Treatments that benefit from PPoC
  • The US in-store clinics model
  • And elsewhere...
  • GSL
  • Self-selection in France, Italy & other countries
  • Dealing with powerful chains - the Five Squeezes
  • Private label
  • Retail Category Management - bringing order out of retail chaos
  • Retail Category Management - the facts
  • Shopper insights
  • Category Captains
  • Is RCM only for Model 1 distribution?
  • Network / Multi-Level Marketing
  • Amway
  • Appendix 1: Key pharmacy chains
  • Appendix 2: Chain pharmacies by region (Americas, Europe, Asia)
  • Appendix 3: Pharmacy chains / groups
  • Appendix 4: Pharmacy chains in China
  • Appendix 5: Pharmacy buying groups and franchises
  • Appendix 6: Suitcase trade (daigou) in China

17. The Digital Revolution

  • GSK's digital / e-Commerce strategy
  • Consumer influences (and influencers)
  • The accelerating trend to greening
  • Digital advertising
  • Successful digital campaigns
  • Sensodyne - "Best in Class" Amazon Case Study
  • Successful apps
  • e-Commerce
  • Olly - Unilever acquires most dynamic brand in US VMS market
  • Blueberry-Eye - Successful direct sales eye health brand
  • Profiles of leading OTC brands on Amazon (USA)
  • Analysis of brands on Amazon across key categories
  • e-Commerce share of key brand sales (USA)
  • Advil - "Best in Class" Amazon Case Study
  • Tylenol - "Best in Class" Amazon Case Study
  • Vicks - "Best in Class" Amazon Case Study
  • Leading OTC brands (USA) - Online purchasing guidance
  • Alibaba Group
  • WebMD

18. Competition - Winners, Survivors & Losers

  • Why are the MNCs underperforming?
  • Key regional / local marketers
  • Top 20 players
  • GlaxoSmithKline
  • J&J
  • Sanofi
  • Bayer
  • Pfizer
  • RB
  • P&G
  • Taisho
  • Takeda
  • Novartis
  • China Resources
  • Otsuka
  • Teva
  • Mondelez
  • The Nature's Bounty Co
  • Prestige Consumer Healthcare
  • Mylan
  • Bausch Health
  • Abbott
  • Perrigo
  • Clorox
  • Nestlé
  • Unilever

19. M&A

  • GSK-Pfizer j-v
  • Are OTC acquisitions always a sideshow of Big Pharma?
  • Multiples
  • Does M&A work?

20. Managing Brands for Long-term Profit Growth

  • What makes a brand?
  • Building brand values, strengthening consumer loyalty
  • Is the OTC industry already generic?
  • Adding value, raising prices
  • Umbrella branding and line extensions - fewer SKUs, more focus
  • Bepanthen / Bepanthol - key franchise in Bayer's CHC portfolio
  • Is Mucinex over-extended?
  • OTC profitability
  • Building critical mass on a global scale

Index of Charts

  • Chart 1: Global all channels OTC sales 2014-18
  • Chart 2: Leading global subcategories by CAGR
  • Chart 3: Current forecast - Most Likely Case
  • Chart 4: Best Case Forecast
  • Chart 5: Worst Case Forecast
  • Chart 6: Global OTC sales 2014-18, plus forecasts
  • Chart 7: Global OTC sales 2014-18
  • Chart 8: Global OTC sales 1995-2018
  • Chart 9: Leading OTC markets 1995 vs 2018
  • Chart 10: Global OTC sales category split 2009-18
  • Chart 11: Global OTC regions by growth rate 2014-18
  • Chart 12: Global OTC growth countries 2014-18
  • Chart 13: Top 20 OTC markets 2018; MAT Q1 2019 sales
  • Chart 14: Top 20 OTC markets 2018 vs 2017
  • Chart 15: Top OTC categories by net contribution to growth 2018
  • Chart 16: North America OTC sales by country 2018
  • Chart 17: USA OTC sales 2014-18
  • Chart 18: North America leading marketers & brands 2018
  • Chart 19: Western Europe OTC sales by country 2018
  • Chart 20: Western Europe OTC sales 2014-18
  • Chart 21: Western Europe leading marketers & brands 2018
  • Chart 22: C&E Europe OTC sales 2014-18
  • Chart 23: C&E Europe leading marketers & brands 27
  • Chart 24: Japan OTC sales 2014-18
  • Chart 25: Japan leading marketers & brands 2018
  • Chart 26: Australasia OTC sales 2014-18
  • Chart 27: Australasia leading marketers & brands 2018
  • Chart 28: Emerging vs developed markets 2014-18
  • Chart 29: Emerging vs developed markets 1995 vs 2018
  • Chart 30: BRICITS markets 2018
  • Chart 31: BRICITS markets 2014-18
  • Chart 32: Brazil leading marketers & brands 2018
  • Chart 33: Russia leading marketers & brands 2018
  • Chart 34: India leading marketers & brands 2018
  • Chart 35: China leading marketers & brands 2018
  • Chart 36: Indonesia leading marketers & brands 2018
  • Chart 37: Turkey leading marketers & brands 2018
  • Chart 38: South Africa leading marketers & brands 2018
  • Chart 39: 2nd tier markets 2018
  • Chart 40: New 3rd tier markets 2018
  • Chart 41: USA ASD prevalence 2000-14 (per 1,000 children)
  • Chart 42: Healthcare expenditure as % of GDP in specific regions 2016
  • Chart 43: Expenditure on pharmaceuticals per capita in OECD markets 2015
  • Chart 44: Global leading pharma players 2018
  • Chart 45: UN estimates for world population by continent 2000 vs 2050
  • Chart 46: UN population forecasts
  • Chart 47: Notable allergy switches in USA
  • Chart 48: Strepsils / Strefen sales 2014-18
  • Chart 49: Leading Mexican brands available in USA 2018
  • Chart 50: Consumer expenditure, disposable income and OTC sales per capita in key Asian markets
  • Chart 51: Number and proportion of people aged 60+ worldwide in 2012, 2030 and
  • Chart 52: Life expectancies (born in 2019)
  • Chart 53: Centrum Silver leading markets 2018
  • Chart 54: Life expectancy at birth by gender mid-2018
  • Chart 55: Women's OTC market value
  • Chart 56: Eve sales 2014-18
  • Chart 57: Men's OTC market value
  • Chart 58: Neutrogena sales
  • Chart 59: Proportion of population overweight by country
  • Chart 60: Proportion of population aged 15+ who smoke by region
  • Chart 61: Top 25 OTC brands 2018
  • Chart 62: USA Rx-to-OTC Switch Pioneers
  • Chart 63: Voltaren sales 2014-18
  • Chart 64: Voltaren sales 1985-2018
  • Chart 65: Global cannabis consumer market
  • Chart 66: CBD and OTC medical cannabis sales
  • Chart 67: CBD supplements, topicals & vaping products sales forecasts by region 2023
  • Chart 68: OTC sexual health sales by category 2018
  • Chart 69: Women's contraceptive choices by method used
  • Chart 70: Global hormonal contraceptives market (by product type)
  • Chart 71: USA share of men and women aged 18 to 30 reporting no sex in past year 1989-2018
  • Chart 72: Global contraceptive devices market by device type 2013
  • Chart 73: Global leading pregnancy vitamin brands 2018
  • Chart 74: Global leading erectile dysfunction brands 2018
  • Chart 75: North America Erectile Dysfunction Drugs Market, by Product 2012-22
  • Chart 76: Global probiotics market by country 2018
  • Chart 77: Top 10 global OTC probiotics brands 2018
  • Chart 78: Probiotics sales & growth by segment 2017
  • Chart 79: OMNi-BiOTiC sales 2014-18
  • Chart 80: Global digestive enzymes sales 2014-18
  • Chart 81: Herbals & naturals sales in leading markets 2017
  • Chart 82: Herbals & naturals sales in leading markets by category 2017
  • Chart 83: Burt's Bees sales 2014-18
  • Chart 84: Zarbee's sales 2014-18
  • Chart 85: Immune supplements sales 2014-18
  • Chart 86: Global sedatives & sleep aids sales 2014-18
  • Chart 87: Global sedatives & sleep aids sales by market 2018
  • Chart 88: ZzzQuil sales 2014-18
  • Chart 89: Global vitamin D sales 2014-18, plus forecast
  • Chart 90: Pharmacy vs mass market by region 266
  • Chart 91: Amway sales (reported) 2014-18
  • Chart 92: Pharmacies by region
  • Chart 93: Key pharmacy chains / groups
  • Chart 94: Number of outlets of leading pharmacy chains in China
  • Chart 95: Annual revenue of leading pharmacy chains in China
  • Chart 96: Net profit of leading pharmacy chains in China
  • Chart 97: Global all channels OTC sales 2014-18
  • Chart 98: Leading markets internet & mail order OTC sales 2018
  • Chart 99: Olly sales 2014-18
  • Chart 100: Blueberry Eye customer numbers 2000-18
  • Chart 101: Advil retail / e-commerce brand sales 318
  • Chart 102: Tylenol retail / e-commerce brand sales 318
  • Chart 103: Vicks retail / e-commerce brand sales 318
  • Chart 104: Alibaba Group sales 2014-2018
  • Chart 105: Leading OTC players 2018
  • Chart 106: OTC growth players 2018
  • Chart 107: GSK sales 2014-18
  • Chart 108: GSK sales by category 2018
  • Chart 109: GSK sales by region 2018
  • Chart 110: GSK leading brands 2018
  • Chart 111: J&J sales 2014-18
  • Chart 112: J&J sales by category 2018
  • Chart 113: J&J sales by region 2018
  • Chart 114: J&J leading brands 2018
  • Chart 115: Sanofi sales 2014-18
  • Chart 116: Sanofi sales by category 2018
  • Chart 117: Sanofi sales by region 2018
  • Chart 118: Sanofi leading brands 2018
  • Chart 119: Bayer sales 2014-18
  • Chart 120: Bayer sales by category 2018
  • Chart 121: Bayer sales by region 2018
  • Chart 122: Bayer leading brands 2018
  • Chart 123: Pfizer sales 2014-18
  • Chart 124: Pfizer sales by category 2018
  • Chart 125: Pfizer sales by region 2018
  • Chart 126: Pfizer leading brands 2018
  • Chart 127: RB sales 2014-18
  • Chart 128: RB sales by category 2018
  • Chart 129: RB sales by region 2018
  • Chart 130: RB leading brands 2018
  • Chart 131: P&G sales 2014-18
  • Chart 132: P&G sales by category 2018
  • Chart 133: P&G sales by region 2018
  • Chart 134: P&G leading brands 2018
  • Chart 135: Taisho sales 2014-18
  • Chart 136: Taisho sales by category 2018
  • Chart 137: Taisho sales by region 2018
  • Chart 138: Taisho leading brands 2018
  • Chart 139: Takeda sales 2014-18
  • Chart 140: Takeda sales by category 2018
  • Chart 141: Takeda sales by region 2018
  • Chart 142: Takeda leading brands 2018
  • Chart 143: Novartis sales 2014-18
  • Chart 144: Novartis sales by category 2018
  • Chart 145: Novartis sales by region 2018
  • Chart 146: Novartis leading brands 2018
  • Chart 147: China Resources 999 sales 2014-18
  • Chart 148: China Resources 999 sales by category
  • Chart 149: China Resources 999 sales by region
  • Chart 150: China Resources 999 leading brands
  • Chart 151: Otsuka sales 2014-18
  • Chart 152: Otsuka sales by category 2018
  • Chart 153: Otsuka sales by region 2018
  • Chart 154: Otsuka leading brands 2018
  • Chart 155: Teva sales 2014-18
  • Chart 156: Teva sales by category 2018
  • Chart 157: Teva sales by region 2018
  • Chart 158: Teva leading brands 2018
  • Chart 159: Mondelez sales 2014-18
  • Chart 160: Mondelez sales by category 2018
  • Chart 161: Mondelez sales by region 2018
  • Chart 162: Mondelez leading brands 2018
  • Chart 163: The Nature's Bounty Co sales 2014-18
  • Chart 164: The Nature's Bounty Co sales by category 2018
  • Chart 165: The Nature's Bounty Co sales by region 2018
  • Chart 166: The Nature's Bounty Co leading brands 2018
  • Chart 167: Prestige CH sales 2014-18
  • Chart 168: Prestige CH sales by category 2018
  • Chart 169: Prestige CH sales by region 2018
  • Chart 170: Prestige CH leading brands 2018
  • Chart 171: Mylan sales 2014-18
  • Chart 172: Mylan sales by category 2018
  • Chart 173: Mylan sales by region 2018
  • Chart 174: Mylan leading brands 2018
  • Chart 175: Bausch Health sales 2014-18
  • Chart 176: Bausch Health sales by category 2018
  • Chart 177: Bausch Health sales by region 2018
  • Chart 178: Bausch Health leading brands 2018
  • Chart 179: Abbott sales 2014-18
  • Chart 180: Abbott sales by category 2018
  • Chart 181: Abbott sales by region 2018
  • Chart 182: Abbott leading brands 2018
  • Chart 183: Perrigo sales 2014-18
  • Chart 184: Perrigo sales by category 2018
  • Chart 185: Perrigo sales by region 2018
  • Chart 186: Perrigo leading brands 2018
  • Chart 187: Clorox sales 2014-18
  • Chart 188: Clorox leading brands 2018
  • Chart 189: Nestlé sales 2014-18
  • Chart 190: Nestlé leading brands 2018
  • Chart 191: Unilever sales 2014-18
  • Chart 192: Unilever leading brands 2018
  • Chart 193: GSK + Pfizer CH sales by category 2018
  • Chart 194: GSK + Pfizer CH growth vs global OTC market 2014-18
  • Chart 195: Key OTC acquisitions & multiples
  • Chart 196: World's Top 100 OTC brands 2018
  • Chart 197: Ratiopharm leading brands in Germany 2018
  • Chart 198: USA OTC adult allergy intra-nasal sprays: comparative launch prices
  • Chart 199: Top 10 global OTC antacid brands 2018
  • Chart 200: Available presentations of selected joint health brands
  • Chart 201: Bepanthen / Bepanthol sales 2014-18
  • Chart 202: Typical P&L for a registered medicines-focused company
  • Chart 203: Leading players operating margins
Back to Top